[Relations between cell-bound lipids and disodium cromoglycate (author's transl)]

Area of Science:

• Immunology
• Pharmacology
• Cell Biology

Context:

• Disodium cromoglycate (DNCG) is a mast cell stabilizer used in asthma prophylaxis.
• The precise molecular mechanism of DNCG's action has been under investigation.
• White blood cells, including mast cells, play a crucial role in allergic responses.

Purpose:

• To investigate the interaction of disodium cromoglycate with cellular lipids.
• To elucidate the potential mechanism of action of DNCG in preventing allergic reactions, specifically in the context of bronchial asthma.

Summary:

• Disodium cromoglycate (DNCG) demonstrates binding affinity for both membrane and intracellular lipids in white blood cells, observed via green fluorescence (515 nm) in treated cell smears.
• This binding interaction suggests a novel mode of action for DNCG, potentially involving the stabilization of mast cell membranes.
• The study proposes that DNCG's interaction with membrane lipids may inhibit the IgE-mediated degranulation of mast cells, thereby preventing the release of vasoactive substances.

Impact:

• Provides a potential molecular explanation for the prophylactic efficacy of disodium cromoglycate in bronchial asthma.
• Highlights the role of lipid binding in the pharmacological activity of DNCG.
• Suggests that targeting cellular lipids could be a therapeutic strategy for allergic diseases.